158 related articles for article (PubMed ID: 35814664)
1. Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.
Wang FD; Zhou J; Li LQ; Wang ML; Tao YC; Wang YH; Zhang DM; Chen EQ
Front Microbiol; 2022; 13():901233. PubMed ID: 35814664
[TBL] [Abstract][Full Text] [Related]
2. HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation.
Xie Y; Li M; Ou X; Zheng S; Gao Y; Xu X; Yang Y; Ma A; Li J; Huang Y; Nan Y; Zheng H; Feng B
J Gastroenterol; 2021 Sep; 56(9):856-867. PubMed ID: 34292372
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B.
Liao G; Ding X; Xia M; Wu Y; Chen H; Fan R; Zhang X; Cai S; Peng J
Int J Gen Med; 2021; 14():4967-4976. PubMed ID: 34483685
[TBL] [Abstract][Full Text] [Related]
4. Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review.
Jaroenlapnopparat A; Chayanupatkul M; Tangkijvanich P
J Gastroenterol Hepatol; 2021 Sep; 36(9):2349-2362. PubMed ID: 33811375
[TBL] [Abstract][Full Text] [Related]
5. Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation.
Xie Y; Li M; Ou X; Zheng S; Gao Y; Xu X; Yang Y; Ma A; Li J; Nan Y; Zheng H; Liu J; Wei L; Feng B
BMC Gastroenterol; 2023 Jun; 23(1):224. PubMed ID: 37386460
[TBL] [Abstract][Full Text] [Related]
6. Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
Fan R; Peng J; Xie Q; Tan D; Xu M; Niu J; Wang H; Ren H; Chen X; Wang M; Sheng J; Tang H; Bai X; Wu Y; Zhou B; Sun J; Hou J;
J Infect Dis; 2020 Jul; 222(4):611-618. PubMed ID: 32211776
[TBL] [Abstract][Full Text] [Related]
7. Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
Cheng HR; Yang HC; Lin SR; Yang TY; Lin YY; Su TH; Tseng TC; Liu CJ; Kao JH
Hepatol Int; 2021 Jun; 15(3):582-592. PubMed ID: 33886088
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients.
Luo M; Zhou B; Hou J; Jiang D
Hepatol Res; 2022 Apr; 52(4):337-351. PubMed ID: 35089634
[TBL] [Abstract][Full Text] [Related]
9. Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy.
Papatheodoridi M; Papachristou E; Moschidis Z; Hadziyannis E; Rigopoulou E; Zachou K; Villeret F; Magiorkinis G; Lyberopoulou A; Gatselis N; Vlachogiannakos I; Manolakopoulos S; Dalekos GN; Zoulim F; Paraskevis D; Papatheodoridis GV
J Viral Hepat; 2022 Nov; 29(11):948-957. PubMed ID: 35789515
[TBL] [Abstract][Full Text] [Related]
10. IP10 and Anti-HBc can Predict Virological Relapse and HBsAg Loss in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Discontinuation.
Xie Y; Li M; Ou X; Zheng S; Gao Y; Xu X; Yang Y; Ma A; Li J; Nan Y; Zheng H; Liu J; Wei L; Feng B
Dig Dis; 2023; 41(6):922-931. PubMed ID: 37586356
[TBL] [Abstract][Full Text] [Related]
11. Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation.
Tseng TN; Jeng WJ; Hu TH; Wang JH; Hung CH; Lu SN; Chen CH
J Antimicrob Chemother; 2023 Feb; 78(2):436-439. PubMed ID: 36478233
[TBL] [Abstract][Full Text] [Related]
12. Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss.
Xue Y; Zhang M; Li T; Liu F; Zhang LX; Fan XP; Yang BH; Wang L
World J Gastroenterol; 2021 Apr; 27(14):1497-1506. PubMed ID: 33911470
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up.
Kaewdech A; Assawasuwannakit S; Sripongpun P; Chamroonkul N; Tangkijvanich P; Piratvisuth T
Front Med (Lausanne); 2022; 9():859430. PubMed ID: 35402452
[TBL] [Abstract][Full Text] [Related]
14. The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients.
Xu WX; Li YM; Li JG; Mei YY; Chen YM; Li XJ; Lin CS; Deng H; Zhao ZX; Xie DY; Gao ZL; Peng L
Gastroenterol Rep (Oxf); 2021 Aug; 9(4):313-322. PubMed ID: 34567563
[TBL] [Abstract][Full Text] [Related]
15. The role of hepatitis B virus core-related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen-negative patients.
Huang PY; Wang JH; Hung CH; Lu SN; Hu TH; Chen CH
J Viral Hepat; 2021 Aug; 28(8):1141-1149. PubMed ID: 33932245
[TBL] [Abstract][Full Text] [Related]
16. Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA.
Liu YY; Liang XS
World J Hepatol; 2018 Sep; 10(9):603-611. PubMed ID: 30310538
[TBL] [Abstract][Full Text] [Related]
17. Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B.
Song DS; Jang JW; Yoo SH; Kwon JH; Nam SW; Bae SH; Choi JY; Yoon SK
Clin Infect Dis; 2021 Aug; 73(4):e892-e903. PubMed ID: 33417679
[TBL] [Abstract][Full Text] [Related]
18. PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation.
Wang CR; Liu XQ; Li H; Zhang Q; Zhong GC; Tang Q; Chang Y; Wang JS; Duan YQ; Hu P
Front Cell Infect Microbiol; 2022; 12():1055774. PubMed ID: 36579348
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B.
Laras A; Papatheodoridi M; Panopoulou E; Papatheodoridis GV; Hadziyannis SJ; Hadziyannis E
Virol J; 2022 Jan; 19(1):22. PubMed ID: 35093105
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α.
Caviglia GP; Abate ML; Noviello D; Olivero A; Rosso C; Troshina G; Ciancio A; Rizzetto M; Saracco GM; Smedile A
Hepatol Res; 2017 Jul; 47(8):747-754. PubMed ID: 27577976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
